Webcast Alert: Rosetta Genomics (ROSG) Announces the LHA Life Sciences & Med Tech Day 2010 Presentation
NEW YORK, July 15 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG) announces the following Webcast:
What: |
LHA Life Sciences & Med Tech Day 2010 Presentation |
|
When: |
July 20, 2010 @ 9:30 AM Eastern |
|
Where: |
http://www.investorcalendar.com/ClientPage.asp?ID=160317 |
|
How: |
Live over the Internet -- Simply log on to the web at the address above. |
|
Contact: |
Cheryl Palazzo, 212-838-3777, [email protected] |
|
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160317 or http://www.investorcalendar.com/
Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company's first three microRNA-based tests, miRview™ squamous, miRview™ mets and miRview™ meso, are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. Rosetta Genomics is the 2008 winner of the Wall Street Journal's Technology Innovation Awards in the medical/biotech category. To learn more, please visit www.rosettagenomics.com.
SOURCE Rosetta Genomics
Share this article